Alzheimer’s Disease
Dec 1, 2020
Amyloid-related Imaging Abnormalities (ARIA): Neuroradiologic Findings in Alzheimer’s Disease Patients Treated with Investigational Anti-Amyloid Therapy
At the virtual Scientific Assembly and Annual Meeting of the Radiological Society of North America, an expert panel discussed the topic of amyloid-related imaging abnormalities (ARIA) in patients with Alzheimer’s disease. Patient case studies highlight the key considerations for optimal detection of ARIA and the management steps that could potentially be taken in clinical practice.
Alzheimer’s Disease
July 27–31, 2020
The Early Diagnosis of Alzheimer’s: Readying the Health System
At the Alzheimer’s Association International Conference 2020, an expert panel outlined the importance of an early diagnosis of Alzheimer’s disease, including the role of clinical assessment tools and biomarkers, alongside the effect of the Covid-19 pandemic.
Alzheimer’s Disease
May 24, 2020
The Early Diagnosis of Alzheimer’s: Delineating the Cause of Memory Impairment
At the virtual 6th Congress of the European Academy of Neurology 2020, an expert panel outlined the importance of an early diagnosis of Alzheimer’s disease (AD) and healthcare system readiness.
Alzheimer’s Disease
April 2, 2020
The Early Diagnosis of Alzheimer’s Disease: Overcoming the Obstacles
At the virtual International Conference on Alzheimer’s and Parkinson’s Disease 2020, an expert panel outlined the importance of an early diagnosis of Alzheimer’s disease (AD). With a complex patient case study at the heart of the discussions, the panel outlined the role of clinical assessment tools and biomarker assessment in a timely diagnosis of AD, with a focus on patients with a young age of symptom onset.
Alzheimer’s Disease
March 29, 2019
The Early Diagnosis of Alzheimer’s: Exploring Pathological Obstacles
At the International Conference on Alzheimer’s and Parkinson’s Disease 2019, an expert panel discussed the clinical presentation of Alzheimer’s disease (AD) in the early stages and outlined the role of cognitive assessment tools and biomarkers in supporting the early diagnosis.
STROKE
February 6, 2019
Understanding Severe Stroke Recognition & Management
At the 2019 International Stroke Conference, Biogen collaborated with a panel of experts to outline and discuss key considerations for the recognition and treatment of large hemispheric infarction (LHI).
Alzheimer’s Disease
July 23, 2018
The Early Diagnosis of Alzheimer’s: Exploring a Patient with Memory Complaints and Identifying Underlying Pathologies
At the Alzheimer’s Association International Conference 2018, an expert panel discussed the importance of an early diagnosis of Alzheimer’s disease (AD).
Alzheimer’s Disease
March 16, 2018
The Early Diagnosis of Alzheimer’s Disease: It’s About Time
At the International Conference on Alzheimer’s and Parkinson’s Disease 2018, faculty highlighted the importance of an early diagnosis of Alzheimer’s disease (AD). With a patient case study, the panel discussed clinical assessment tools and biomarkers, alongside patient management following an early diagnosis of AD.